
Why lowering drug costs can start with machine learning and better patient interaction.
Robert S. Oscar, R.Ph. CEO/president of RxEOB, has more than 25 years of experience in healthcare, having developed and implemented successful programs to effectively manage pharmacy benefit risk, including pioneering work in the Medicare HMO market. In 2
Why lowering drug costs can start with machine learning and better patient interaction.
Medication non-adherence is a growing issue for patients, physicians and health plans. Here’s one effective solution.
Learning to use mobile health or mhealth is a critical advantage to providing the highest return on investment for plans and providers.
Published: March 14th 2016 | Updated:
Published: June 10th 2016 | Updated:
Published: June 22nd 2019 | Updated: